GlassScriptPhysician profile
Jason Vincent
NPI 1912504812
$1,249.37
in general payments reported to CMS, 2019-2025
17 companies · $581 in 2025
The $581 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $93.70 · 2023: $217 · 2024: $358 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $503.29 | 2025 | General - Pain Management |
| Merck Sharp & Dohme LLC | $132.10 | 2023-2025 | Keytruda, Lynparza |
| Angiodynamics, INC. | $90.99 | 2023-2024 | Solero, Biosentry Tract Sealant System |
| Daiichi Sankyo INC. | $85.20 | 2023-2024 | Enhertu |
| Grt US Holding, INC. | $60.00 | 2022 | |
| Pfizer INC. | $48.89 | 2024 | |
| Glaxosmithkline, LLC. | $48.30 | 2024 | Ojjaara, Jemperli |
| Seagen INC. | $41.38 | 2023 | Padcev, Tukysa |
| Janssen Biotech, INC. | $39.79 | 2024 | Carvykti, Talvey, Rybrevant |
| Novartis Pharmaceuticals Corporation | $39.03 | 2023-2024 | |
| Eisai INC. | $32.70 | 2022-2023 | |
| Kite Pharma, INC. | $29.99 | 2024 | |
| Janssen Scientific Affairs, LLC | $24.50 | 2024 | Balversa |
| Stemline Therapeutics INC. | $20.67 | 2023 | Orserdu |
| Incyte Corporation | $18.58 | 2024 | Jakafi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.36 | 2022 | |
| Mml US, INC. | $15.60 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Vincent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.